ITGA6 and neoplasm: The ex vivo approach described here with the purification of different cell types (EpCAM/CD49f) prior to adenovirus treatment could be used to definitively identify the cell of origin and study how the cell of origin impacts tumor formation, progression, and immunotherapy responses [49,50,51].